ID

44325

Description

ODM derived from http://clinicaltrials.gov/show/NCT00332709

Link

http://clinicaltrials.gov/show/NCT00332709

Keywords

Versions (4)
  1. 12/11/13 12/11/13 - Martin Dugas
  2. 4/14/14 4/14/14 - Julian Varghese
  3. 9/2/21 9/2/21 -
  4. 9/20/21 9/20/21 -
Uploaded on

September 20, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00332709 Osteoporosis. Postmenopausal

German English

Eligibility

1 forms  
  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI 2011AA
CL425202
Age 18 Years and older
Description

age >=18 Years

Data type

boolean

Alias
UMLS CUI 2011AA
C0001779
SNOMED CT 2011_0131
397669002
Compliant postmenopausal women with primary operable breast cancer after 4 to 6 years of therapy with tamoxifen (end of tamoxifen therapy within last 6 months)
Description

Compliant postmenopausal women with primary operable breast cancer after 4 to 6 years of therapy with tamoxifen (end of tamoxifen therapy within last 6 months)

Data type

boolean

Alias
UMLS CUI 2011AA
C0011900
SNOMED CT 2011_0131
439401001
LOINC Version 232
MTHU008876
UMLS CUI 2011AA
C0566588
SNOMED CT 2011_0131
289172004
UMLS CUI 2011AA
C0232970
SNOMED CT 2011_0131
76498008
UMLS CUI 2011AA
C0043210
SNOMED CT 2011_0131
224526002
UMLS CUI 2011AA
CL414904
UMLS CUI 2011AA
C0205188
SNOMED CT 2011_0131
76234009
UMLS CUI 2011AA
C0678222
SNOMED CT 2011_0131
254838004
MedDRA 14.1
10006204
UMLS CUI 2011AA
C0039798
UMLS CUI 2011AA
C0205088
SNOMED CT 2011_0131
42796001
UMLS CUI 2011AA
C0039286
SNOMED CT 2011_0131
373345002
LOINC Version 232
MTHU003102
ECOG performance status finding
Description

Performance status <=2 (Eastern Cooperative Oncology Group)

Data type

boolean

Alias
UMLS CUI 2011AA
C1520224
SNOMED CT 2011_0131
424122007
Patients without severe osteoporosis at study entry
Description

Patients without severe osteoporosis at study entry

Data type

boolean

Alias
UMLS CUI 2011AA
C0332288
SNOMED CT 2011_0131
45169001
UMLS CUI 2011AA
C1859443
UMLS CUI 2011AA
C0008976
SNOMED CT 2011_0131
110465008
UMLS CUI 2011AA
C1705654
No evidence of relapse at the time of randomization
Description

No evidence of relapse at the time of randomization

Data type

boolean

Alias
UMLS CUI 2011AA
C0332125
SNOMED CT 2011_0131
41647002
UMLS CUI 2011AA
C0277556
SNOMED CT 2011_0131
58184002
UMLS CUI 2011AA
C0040223
SNOMED CT 2011_0131
410670007
LOINC Version 232
MTHU009151
UMLS CUI 2011AA
C0034656
Adequate function of bone marrow, kidney, and liver
Description

Adequate function of bone marrow, kidney, and liver

Data type

boolean

Alias
UMLS CUI 2011AA
C0205411
SNOMED CT 2011_0131
88323005
UMLS CUI 2011AA
C0598463
LOINC Version 232
MTHU027728
UMLS CUI 2011AA
C0005953
SNOMED CT 2011_0131
14016003
LOINC Version 232
MTHU016536
UMLS CUI 2011AA
C0232804
SNOMED CT 2011_0131
11953005
UMLS CUI 2011AA
C0232741
SNOMED CT 2011_0131
79036002
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI 2011AA
CL425201
Estrogen- and progesterone-receptor status negative or unknown
Description

Estrogen- and progesterone-receptor status negative or unknown

Data type

boolean

Alias
UMLS CUI 2011AA
C1516974
UMLS CUI 2011AA
CL415098
UMLS CUI 2011AA
C0279758
UMLS CUI 2011AA
C1514471
UMLS CUI 2011AA
CL415098
UMLS CUI 2011AA
C0279768
Completion of adjuvant tamoxifen therapy more than 6 months prior to study start
Description

Completion of adjuvant tamoxifen therapy more than 6 months prior to study start

Data type

boolean

Alias
UMLS CUI 2011AA
C0580352
SNOMED CT 2011_0131
182992009
UMLS CUI 2011AA
C1522673
UMLS CUI 2011AA
C0039286
SNOMED CT 2011_0131
373345002
LOINC Version 232
MTHU003102
UMLS CUI 2011AA
C0332152
SNOMED CT 2011_0131
288556008
UMLS CUI 2011AA
C2348558
Inflammatory Breast Carcinoma, Mastitis carcinomatosa
Description

Inflammatory breast cancer

Data type

boolean

Alias
UMLS CUI 2011AA
C0278601
SNOMED CT 2011_0131
254840009
MedDRA 14.1
10021980
Current/active dental problems including infection of the teeth or jawbone, dental or fixture trauma, or a current or prior diagnosis of osteonecrosis of the jaw, of exposed bone in the mouth, or of slow healing after dental procedures
Description

Current/active dental problems including infection of the teeth or jawbone, dental or fixture trauma, or a current or prior diagnosis of osteonecrosis of the jaw, of exposed bone in the mouth, or of slow healing after dental procedures

Data type

boolean

Alias
UMLS CUI 2011AA
C0521116
SNOMED CT 2011_0131
15240007
UMLS CUI 2011AA
C0205177
SNOMED CT 2011_0131
55561003
UMLS CUI 2011AA
C1704330
SNOMED CT 2011_0131
105995000
MedDRA 14.1
10012322
ICD-10-CM Version 2010
K08.9
ICD-9-CM Version 2011
525.9
UMLS CUI 2011AA
CL425202
UMLS CUI 2011AA
C0877046
SNOMED CT 2011_0131
427898007
MedDRA 14.1
10048762
CTCAE 1105E
E11594
UMLS CUI 2011AA
C1400570
UMLS CUI 2011AA
C1301685
SNOMED CT 2011_0131
397869004
UMLS CUI 2011AA
C2363483
UMLS CUI 2011AA
C0175677
SNOMED CT 2011_0131
417746004
MedDRA 14.1
10022116
ICD-10-CM Version 2010
T14.9
UMLS CUI 2011AA
C0521116
SNOMED CT 2011_0131
15240007
UMLS CUI 2011AA
C0332152
SNOMED CT 2011_0131
288556008
UMLS CUI 2011AA
C0011900
SNOMED CT 2011_0131
439401001
LOINC Version 232
MTHU008876
UMLS CUI 2011AA
C2711248
MedDRA 14.1
10064658
CTCAE 1105E
E12502
UMLS CUI 2011AA
CL428750
MedDRA 14.1
10071014
UMLS CUI 2011AA
C0439834
SNOMED CT 2011_0131
255361000
UMLS CUI 2011AA
C2004454
UMLS CUI 2011AA
C0231290
SNOMED CT 2011_0131
237679004, 255234002
UMLS CUI 2011AA
C0011331
SNOMED CT 2011_0131
108306002
MedDRA 14.1
10061813
LOINC Version 232
MTHU015835
Recent (within 6 weeks) or planned dental or jaw surgery
Description

Recent (within 6 weeks) or planned dental or jaw surgery

Data type

boolean

Alias
UMLS CUI 2011AA
C0332185
SNOMED CT 2011_0131
6493001
UMLS CUI 2011AA
C1301732
SNOMED CT 2011_0131
397943006
UMLS CUI 2011AA
C0204324
SNOMED CT 2011_0131
81733005
MedDRA 14.1
10061812
UMLS CUI 2011AA
C0524861
MedDRA 14.1
10051059
History of diseases with influence on bone metabolism such as Paget's disease and primary overactive parathyroid
Description

History of diseases with influence on bone metabolism such as Paget's disease and primary overactive parathyroid

Data type

boolean

Alias
UMLS CUI 2011AA
CL421546
SNOMED CT 2011_0131
392521001
UMLS CUI 2011AA
C0012634
SNOMED CT 2011_0131
64572001
UMLS CUI 2011AA
C0814606
UMLS CUI 2011AA
C0596204
UMLS CUI 2011AA
C1368019
UMLS CUI 2011AA
CL414904
UMLS CUI 2011AA
C0443272
SNOMED CT 2011_0131
263829006
MedDRA 14.1
10033288
UMLS CUI 2011AA
C0030517
SNOMED CT 2011_0131
73132005
MedDRA 14.1
10033942
ICD-10-CM Version 2010
E21.5
ICD-9-CM Version 2011
252.9
Prior or concomitant therapies: chemotherapy within the last 12 months, intravenous or oral bisphosphonates, systemic corticosteroids, anabolic steroids or growth hormones, Tibolone, parathyroid hormone, systemic sodium fluoride or any drugs known to affect the skeleton (such as calcitonin, mithramycin, or gallium nitrate)
Description

Prior or concomitant therapies: chemotherapy within the last 12 months, intravenous or oral bisphosphonates, systemic corticosteroids, anabolic steroids or growth hormones, Tibolone, parathyroid hormone, systemic sodium fluoride or any drugs known to affect the skeleton (such as calcitonin, mithramycin, or gallium nitrate)

Data type

boolean

Alias
UMLS CUI 2011AA
C0332152
SNOMED CT 2011_0131
288556008
UMLS CUI 2011AA
CL415222
UMLS CUI 2011AA
C0039798
UMLS CUI 2011AA
C0392920
SNOMED CT 2011_0131
150415003
UMLS CUI 2011AA
C0348016
SNOMED CT 2011_0131
255560000
UMLS CUI 2011AA
C1527415
SNOMED CT 2011_0131
26643006
HL7 V3 2006_05
_OralRoute
UMLS CUI 2011AA
C0012544
SNOMED CT 2011_0131
372907000
UMLS CUI 2011AA
C0205373
SNOMED CT 2011_0131
31099001
UMLS CUI 2011AA
C0001617
SNOMED CT 2011_0131
79440004
UMLS CUI 2011AA
C0002845
SNOMED CT 2011_0131
111151007
LOINC Version 232
MTHU019429
UMLS CUI 2011AA
C1258800
UMLS CUI 2011AA
C0037663
SNOMED CT 2011_0131
56234005
LOINC Version 232
MTHU002890
UMLS CUI 2011AA
C0076660
SNOMED CT 2011_0131
395903002
UMLS CUI 2011AA
C0030520
SNOMED CT 2011_0131
4076007
LOINC Version 232
MTHU005026
UMLS CUI 2011AA
C0205373
SNOMED CT 2011_0131
31099001
UMLS CUI 2011AA
C0037508
SNOMED CT 2011_0131
6910009
UMLS CUI 2011AA
C0013227
UMLS CUI 2011AA
C0205309
SNOMED CT 2011_0131
36692007
UMLS CUI 2011AA
C0814606
UMLS CUI 2011AA
C1283922
SNOMED CT 2011_0131
361378004
UMLS CUI 2011AA
C0006668
SNOMED CT 2011_0131
63730009
LOINC Version 232
MTHU003443
UMLS CUI 2011AA
C0026234
SNOMED CT 2011_0131
387101002
UMLS CUI 2011AA
C0061008
SNOMED CT 2011_0131
109092007
Patients with previous or concomitant cancers (not breast cancer) within the past 5 years EXCEPT adequately treated basal or squamous cell skin cancers or in situ cancer of the cervix. Patients with previous other cancer(s) must have been disease-free for at least 5 years.
Description

Patients with previous or concomitant cancers (not breast cancer) within the past 5 years EXCEPT adequately treated basal or squamous cell skin cancers or in situ cancer of the cervix. Patients with previous other cancer(s) must have been disease-free for at least 5 years.

Data type

boolean

Alias
UMLS CUI 2011AA
C0205156
SNOMED CT 2011_0131
9130008
UMLS CUI 2011AA
CL415222
UMLS CUI 2011AA
C0006826
SNOMED CT 2011_0131
363346000
MedDRA 14.1
10028997
LOINC Version 232
MTHU010328
ICD-10-CM Version 2010
C00-C96
UMLS CUI 2011AA
C1518422
UMLS CUI 2011AA
C0678222
SNOMED CT 2011_0131
254838004
MedDRA 14.1
10006204
UMLS CUI 2011AA
C1554961
HL7 V3 2006_05
E
UMLS CUI 2011AA
C0205411
SNOMED CT 2011_0131
88323005
UMLS CUI 2011AA
CL415147
UMLS CUI 2011AA
C0007117
SNOMED CT 2011_0131
1338007
MedDRA 14.1
10004146
UMLS CUI 2011AA
C0553723
SNOMED CT 2011_0131
254651007
MedDRA 14.1
10041834
UMLS CUI 2011AA
C0851140
SNOMED CT 2011_0131
92564006
MedDRA 14.1
10061809
ICD-10-CM Version 2010
D06.9
ICD-9-CM Version 2011
233.1
UMLS CUI 2011AA
C0332288
SNOMED CT 2011_0131
45169001
UMLS CUI 2011AA
C0012634
SNOMED CT 2011_0131
64572001
Patients currently receiving oral bisphosphonates must discontinue these at least 3 weeks prior to study start.
Description

Patients currently receiving oral bisphosphonates must discontinue these at least 3 weeks prior to study start.

Data type

boolean

Alias
UMLS CUI 2011AA
C0521116
SNOMED CT 2011_0131
15240007
UMLS CUI 2011AA
C1514756
UMLS CUI 2011AA
C1527415
SNOMED CT 2011_0131
26643006
HL7 V3 2006_05
_OralRoute
UMLS CUI 2011AA
C0012544
SNOMED CT 2011_0131
372907000
UMLS CUI 2011AA
C0457454
SNOMED CT 2011_0131
278308006
UMLS CUI 2011AA
C0332152
SNOMED CT 2011_0131
288556008
UMLS CUI 2011AA
C2348558
Back to the top of the page

Similar models

Eligibility

1 forms
  1. StudyEvent: Eligibility
    1. Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Inclusion Criteria
CL425202 (UMLS CUI 2011AA)
age >=18 Years
Item
Age 18 Years and older
boolean
C0001779 (UMLS CUI 2011AA)
397669002 (SNOMED CT 2011_0131)
Compliant postmenopausal women with primary operable breast cancer after 4 to 6 years of therapy with tamoxifen (end of tamoxifen therapy within last 6 months)
Item
Compliant postmenopausal women with primary operable breast cancer after 4 to 6 years of therapy with tamoxifen (end of tamoxifen therapy within last 6 months)
boolean
C0011900 (UMLS CUI 2011AA)
439401001 (SNOMED CT 2011_0131)
MTHU008876 (LOINC Version 232)
C0566588 (UMLS CUI 2011AA)
289172004 (SNOMED CT 2011_0131)
C0232970 (UMLS CUI 2011AA)
76498008 (SNOMED CT 2011_0131)
C0043210 (UMLS CUI 2011AA)
224526002 (SNOMED CT 2011_0131)
CL414904 (UMLS CUI 2011AA)
C0205188 (UMLS CUI 2011AA)
76234009 (SNOMED CT 2011_0131)
C0678222 (UMLS CUI 2011AA)
254838004 (SNOMED CT 2011_0131)
10006204 (MedDRA 14.1)
C0039798 (UMLS CUI 2011AA)
C0205088 (UMLS CUI 2011AA)
42796001 (SNOMED CT 2011_0131)
C0039286 (UMLS CUI 2011AA)
373345002 (SNOMED CT 2011_0131)
MTHU003102 (LOINC Version 232)
Performance status <=2 (Eastern Cooperative Oncology Group)
Item
ECOG performance status finding
boolean
C1520224 (UMLS CUI 2011AA)
424122007 (SNOMED CT 2011_0131)
Patients without severe osteoporosis at study entry
Item
Patients without severe osteoporosis at study entry
boolean
C0332288 (UMLS CUI 2011AA)
45169001 (SNOMED CT 2011_0131)
C1859443 (UMLS CUI 2011AA)
C0008976 (UMLS CUI 2011AA)
110465008 (SNOMED CT 2011_0131)
C1705654 (UMLS CUI 2011AA)
No evidence of relapse at the time of randomization
Item
No evidence of relapse at the time of randomization
boolean
C0332125 (UMLS CUI 2011AA)
41647002 (SNOMED CT 2011_0131)
C0277556 (UMLS CUI 2011AA)
58184002 (SNOMED CT 2011_0131)
C0040223 (UMLS CUI 2011AA)
410670007 (SNOMED CT 2011_0131)
MTHU009151 (LOINC Version 232)
C0034656 (UMLS CUI 2011AA)
Adequate function of bone marrow, kidney, and liver
Item
Adequate function of bone marrow, kidney, and liver
boolean
C0205411 (UMLS CUI 2011AA)
88323005 (SNOMED CT 2011_0131)
C0598463 (UMLS CUI 2011AA)
MTHU027728 (LOINC Version 232)
C0005953 (UMLS CUI 2011AA)
14016003 (SNOMED CT 2011_0131)
MTHU016536 (LOINC Version 232)
C0232804 (UMLS CUI 2011AA)
11953005 (SNOMED CT 2011_0131)
C0232741 (UMLS CUI 2011AA)
79036002 (SNOMED CT 2011_0131)
Item Group
Exclusion Criteria
CL425201 (UMLS CUI 2011AA)
Estrogen- and progesterone-receptor status negative or unknown
Item
Estrogen- and progesterone-receptor status negative or unknown
boolean
C1516974 (UMLS CUI 2011AA)
CL415098 (UMLS CUI 2011AA)
C0279758 (UMLS CUI 2011AA)
C1514471 (UMLS CUI 2011AA)
CL415098 (UMLS CUI 2011AA)
C0279768 (UMLS CUI 2011AA)
Completion of adjuvant tamoxifen therapy more than 6 months prior to study start
Item
Completion of adjuvant tamoxifen therapy more than 6 months prior to study start
boolean
C0580352 (UMLS CUI 2011AA)
182992009 (SNOMED CT 2011_0131)
C1522673 (UMLS CUI 2011AA)
C0039286 (UMLS CUI 2011AA)
373345002 (SNOMED CT 2011_0131)
MTHU003102 (LOINC Version 232)
C0332152 (UMLS CUI 2011AA)
288556008 (SNOMED CT 2011_0131)
C2348558 (UMLS CUI 2011AA)
Inflammatory breast cancer
Item
Inflammatory Breast Carcinoma, Mastitis carcinomatosa
boolean
C0278601 (UMLS CUI 2011AA)
254840009 (SNOMED CT 2011_0131)
10021980 (MedDRA 14.1)
Current/active dental problems including infection of the teeth or jawbone, dental or fixture trauma, or a current or prior diagnosis of osteonecrosis of the jaw, of exposed bone in the mouth, or of slow healing after dental procedures
Item
Current/active dental problems including infection of the teeth or jawbone, dental or fixture trauma, or a current or prior diagnosis of osteonecrosis of the jaw, of exposed bone in the mouth, or of slow healing after dental procedures
boolean
C0521116 (UMLS CUI 2011AA)
15240007 (SNOMED CT 2011_0131)
C0205177 (UMLS CUI 2011AA)
55561003 (SNOMED CT 2011_0131)
C1704330 (UMLS CUI 2011AA)
105995000 (SNOMED CT 2011_0131)
10012322 (MedDRA 14.1)
K08.9 (ICD-10-CM Version 2010)
525.9 (ICD-9-CM Version 2011)
CL425202 (UMLS CUI 2011AA)
C0877046 (UMLS CUI 2011AA)
427898007 (SNOMED CT 2011_0131)
10048762 (MedDRA 14.1)
E11594 (CTCAE 1105E)
C1400570 (UMLS CUI 2011AA)
C1301685 (UMLS CUI 2011AA)
397869004 (SNOMED CT 2011_0131)
C2363483 (UMLS CUI 2011AA)
C0175677 (UMLS CUI 2011AA)
417746004 (SNOMED CT 2011_0131)
10022116 (MedDRA 14.1)
T14.9 (ICD-10-CM Version 2010)
C0521116 (UMLS CUI 2011AA)
15240007 (SNOMED CT 2011_0131)
C0332152 (UMLS CUI 2011AA)
288556008 (SNOMED CT 2011_0131)
C0011900 (UMLS CUI 2011AA)
439401001 (SNOMED CT 2011_0131)
MTHU008876 (LOINC Version 232)
C2711248 (UMLS CUI 2011AA)
10064658 (MedDRA 14.1)
E12502 (CTCAE 1105E)
CL428750 (UMLS CUI 2011AA)
10071014 (MedDRA 14.1)
C0439834 (UMLS CUI 2011AA)
255361000 (SNOMED CT 2011_0131)
C2004454 (UMLS CUI 2011AA)
C0231290 (UMLS CUI 2011AA)
237679004, 255234002 (SNOMED CT 2011_0131)
C0011331 (UMLS CUI 2011AA)
108306002 (SNOMED CT 2011_0131)
10061813 (MedDRA 14.1)
MTHU015835 (LOINC Version 232)
Recent (within 6 weeks) or planned dental or jaw surgery
Item
Recent (within 6 weeks) or planned dental or jaw surgery
boolean
C0332185 (UMLS CUI 2011AA)
6493001 (SNOMED CT 2011_0131)
C1301732 (UMLS CUI 2011AA)
397943006 (SNOMED CT 2011_0131)
C0204324 (UMLS CUI 2011AA)
81733005 (SNOMED CT 2011_0131)
10061812 (MedDRA 14.1)
C0524861 (UMLS CUI 2011AA)
10051059 (MedDRA 14.1)
History of diseases with influence on bone metabolism such as Paget's disease and primary overactive parathyroid
Item
History of diseases with influence on bone metabolism such as Paget's disease and primary overactive parathyroid
boolean
CL421546 (UMLS CUI 2011AA)
392521001 (SNOMED CT 2011_0131)
C0012634 (UMLS CUI 2011AA)
64572001 (SNOMED CT 2011_0131)
C0814606 (UMLS CUI 2011AA)
C0596204 (UMLS CUI 2011AA)
C1368019 (UMLS CUI 2011AA)
CL414904 (UMLS CUI 2011AA)
C0443272 (UMLS CUI 2011AA)
263829006 (SNOMED CT 2011_0131)
10033288 (MedDRA 14.1)
C0030517 (UMLS CUI 2011AA)
73132005 (SNOMED CT 2011_0131)
10033942 (MedDRA 14.1)
E21.5 (ICD-10-CM Version 2010)
252.9 (ICD-9-CM Version 2011)
Prior or concomitant therapies: chemotherapy within the last 12 months, intravenous or oral bisphosphonates, systemic corticosteroids, anabolic steroids or growth hormones, Tibolone, parathyroid hormone, systemic sodium fluoride or any drugs known to affect the skeleton (such as calcitonin, mithramycin, or gallium nitrate)
Item
Prior or concomitant therapies: chemotherapy within the last 12 months, intravenous or oral bisphosphonates, systemic corticosteroids, anabolic steroids or growth hormones, Tibolone, parathyroid hormone, systemic sodium fluoride or any drugs known to affect the skeleton (such as calcitonin, mithramycin, or gallium nitrate)
boolean
C0332152 (UMLS CUI 2011AA)
288556008 (SNOMED CT 2011_0131)
CL415222 (UMLS CUI 2011AA)
C0039798 (UMLS CUI 2011AA)
C0392920 (UMLS CUI 2011AA)
150415003 (SNOMED CT 2011_0131)
C0348016 (UMLS CUI 2011AA)
255560000 (SNOMED CT 2011_0131)
C1527415 (UMLS CUI 2011AA)
26643006 (SNOMED CT 2011_0131)
_OralRoute (HL7 V3 2006_05)
C0012544 (UMLS CUI 2011AA)
372907000 (SNOMED CT 2011_0131)
C0205373 (UMLS CUI 2011AA)
31099001 (SNOMED CT 2011_0131)
C0001617 (UMLS CUI 2011AA)
79440004 (SNOMED CT 2011_0131)
C0002845 (UMLS CUI 2011AA)
111151007 (SNOMED CT 2011_0131)
MTHU019429 (LOINC Version 232)
C1258800 (UMLS CUI 2011AA)
C0037663 (UMLS CUI 2011AA)
56234005 (SNOMED CT 2011_0131)
MTHU002890 (LOINC Version 232)
C0076660 (UMLS CUI 2011AA)
395903002 (SNOMED CT 2011_0131)
C0030520 (UMLS CUI 2011AA)
4076007 (SNOMED CT 2011_0131)
MTHU005026 (LOINC Version 232)
C0205373 (UMLS CUI 2011AA)
31099001 (SNOMED CT 2011_0131)
C0037508 (UMLS CUI 2011AA)
6910009 (SNOMED CT 2011_0131)
C0013227 (UMLS CUI 2011AA)
C0205309 (UMLS CUI 2011AA)
36692007 (SNOMED CT 2011_0131)
C0814606 (UMLS CUI 2011AA)
C1283922 (UMLS CUI 2011AA)
361378004 (SNOMED CT 2011_0131)
C0006668 (UMLS CUI 2011AA)
63730009 (SNOMED CT 2011_0131)
MTHU003443 (LOINC Version 232)
C0026234 (UMLS CUI 2011AA)
387101002 (SNOMED CT 2011_0131)
C0061008 (UMLS CUI 2011AA)
109092007 (SNOMED CT 2011_0131)
Patients with previous or concomitant cancers (not breast cancer) within the past 5 years EXCEPT adequately treated basal or squamous cell skin cancers or in situ cancer of the cervix. Patients with previous other cancer(s) must have been disease-free for at least 5 years.
Item
Patients with previous or concomitant cancers (not breast cancer) within the past 5 years EXCEPT adequately treated basal or squamous cell skin cancers or in situ cancer of the cervix. Patients with previous other cancer(s) must have been disease-free for at least 5 years.
boolean
C0205156 (UMLS CUI 2011AA)
9130008 (SNOMED CT 2011_0131)
CL415222 (UMLS CUI 2011AA)
C0006826 (UMLS CUI 2011AA)
363346000 (SNOMED CT 2011_0131)
10028997 (MedDRA 14.1)
MTHU010328 (LOINC Version 232)
C00-C96 (ICD-10-CM Version 2010)
C1518422 (UMLS CUI 2011AA)
C0678222 (UMLS CUI 2011AA)
254838004 (SNOMED CT 2011_0131)
10006204 (MedDRA 14.1)
C1554961 (UMLS CUI 2011AA)
E (HL7 V3 2006_05)
C0205411 (UMLS CUI 2011AA)
88323005 (SNOMED CT 2011_0131)
CL415147 (UMLS CUI 2011AA)
C0007117 (UMLS CUI 2011AA)
1338007 (SNOMED CT 2011_0131)
10004146 (MedDRA 14.1)
C0553723 (UMLS CUI 2011AA)
254651007 (SNOMED CT 2011_0131)
10041834 (MedDRA 14.1)
C0851140 (UMLS CUI 2011AA)
92564006 (SNOMED CT 2011_0131)
10061809 (MedDRA 14.1)
D06.9 (ICD-10-CM Version 2010)
233.1 (ICD-9-CM Version 2011)
C0332288 (UMLS CUI 2011AA)
45169001 (SNOMED CT 2011_0131)
C0012634 (UMLS CUI 2011AA)
64572001 (SNOMED CT 2011_0131)
Patients currently receiving oral bisphosphonates must discontinue these at least 3 weeks prior to study start.
Item
Patients currently receiving oral bisphosphonates must discontinue these at least 3 weeks prior to study start.
boolean
C0521116 (UMLS CUI 2011AA)
15240007 (SNOMED CT 2011_0131)
C1514756 (UMLS CUI 2011AA)
C1527415 (UMLS CUI 2011AA)
26643006 (SNOMED CT 2011_0131)
_OralRoute (HL7 V3 2006_05)
C0012544 (UMLS CUI 2011AA)
372907000 (SNOMED CT 2011_0131)
C0457454 (UMLS CUI 2011AA)
278308006 (SNOMED CT 2011_0131)
C0332152 (UMLS CUI 2011AA)
288556008 (SNOMED CT 2011_0131)
C2348558 (UMLS CUI 2011AA)
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial